Keyphrases
Posttraumatic Stress Disorder
100%
Epidermis
69%
Post-traumatic
66%
Cell-free DNA (cfDNA)
66%
Associative Memory
64%
Memory Impairment
59%
Alternative Splicing
59%
Acetylcholinesterase
56%
Melanoma
49%
Acute Stress Disorder
42%
Epidermal Morphogenesis
39%
T Cells
38%
Gene Expression Programming
37%
Interhemispheric Connectivity
37%
Plasma Cells
37%
Cell of Origin
37%
Chromatin Immunoprecipitation (ChIP)
37%
Melanoma Vaccine
37%
SLAMF6
37%
Immune Checkpoint Molecules
37%
Cell-free
37%
Corpus Callosum
37%
In Cancer
37%
Cancer Patients
36%
Brain Metastases
34%
Memory Performance
33%
Programmed Death-ligand 1 (PD-L1)
30%
Melanoma Cells
29%
Metastatic Colorectal Cancer (mCRC)
28%
Tumor
28%
Associative Memory Deficit
27%
Immune Monitoring
26%
Apoptosis
26%
Adjuvant Therapy
25%
Melanoma Patients
25%
Epidermal Proliferation
25%
Evade
25%
Chemotherapy
25%
Checkpoint Inhibitors
24%
Transgenic
24%
Stress-induced
24%
Corpus Callosum Volume
23%
Posttraumatic Stress
23%
Pathological Process
23%
Liquid Biopsy
23%
Costimulatory Molecules
22%
Actin Polymerization
21%
Episodic Memory
21%
New Memory
21%
New Learning
21%
Medicine and Dentistry
Biological Marker
61%
Nodular Melanoma
56%
Malignant Neoplasm
44%
Gene Expression
44%
Neoplasm
42%
Brain Metastasis
41%
Retrospective Study
37%
Plasma Cell
37%
Melanoma Vaccine
37%
Cell-Free DNA
37%
Nucleosome
37%
Programmed Cell Death
37%
Disease
34%
Immunotherapy
32%
Melanoma Cell
29%
Colorectal Carcinoma
28%
Cell Line
28%
Overall Survival
28%
CD8 Antigen
25%
Adjuvant Therapy
25%
Astrocyte
25%
Solid Malignant Neoplasm
23%
Neck
23%
Cell Death
22%
Cytotoxic T-Cell
21%
Radiation Therapy
18%
Cellular Senescence
18%
Predictive Marker
18%
Salivary Gland Function
18%
Patient Monitoring
18%
CTLA-4
18%
Pathological Process
18%
Cutaneous T Cell Lymphoma
18%
Salivary Gland
18%
Division
18%
Whole Cell
18%
Ticilimumab
18%
Stomach Carcinoma
18%
Tissue Injury
18%
Ipilimumab
18%
Systemic Therapy
18%
CD137 Ligand
18%
Tumor Initiation
18%
Durvalumab
18%
DNA Mismatch Repair
18%
Hyperplasia
18%
Delayed Hypersensitivity
18%
Cell Division
18%
Cell Therapy
18%
Brain Injury
18%